Zhejiang Huahai Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Zhejiang Huahai Pharmaceutical Stock Forecast and Price Target
The average price target for Zhejiang Huahai Pharmaceutical's stock lately set by several renowned analysts is ¥19.50, which would result in a potential upside of approximately 16.42% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of ¥21.00 and a low estimate of ¥14.00. If you are interested in 600521 stock, it is important to also consider its competitors.
16.42% Upside
Zhejiang Huahai Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's Price has gone down from ¥30.11 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach ¥47.31 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Zhejiang Huahai Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's Revenue has grown, rising from ¥6.49B to ¥8.31B – a growth of 28.12%. In the next year, 0 analysts estimate that Zhejiang Huahai Pharmaceutical's Revenue will decrease by 7.51%, reaching ¥7.68B. According to professional forecasts, in 2030, Zhejiang Huahai Pharmaceutical's Revenue will decrease by 7.67%, reaching ¥7.67B.
.jpg)
Zhejiang Huahai Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's Dividend per Share has fallen from ¥0.20 to ¥0.20 – a 0.00% decrease. In the next year, analysts believe that Dividend per Share will reach ¥0.25 – an increase of 25.00%. For the next seven years, experts predict that Zhejiang Huahai Pharmaceutical's Dividend per Share will grow at a rate of 19.18%.
Zhejiang Huahai Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's EBITDA has decreased by 4.16%, going from ¥1.84B to ¥1.76B. For the next year, analysts predict that EBITDA will reach ¥2.68B – an increase of 52.23%. Over the next seven years, experts believe that Zhejiang Huahai Pharmaceutical's EBITDA will grow at a rate of 58.40%.
Zhejiang Huahai Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's EBIT has decreased from ¥1.37B to ¥1.12B – a 18.52% drop. In the next year, analysts predict that EBIT will jump to ¥1.72B – up 53.62% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 66.38%.
Zhejiang Huahai Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Zhejiang Huahai Pharmaceutical's EPS has gone down from ¥0.56 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach ¥0.88 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)